Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Marc Yates
  • November 10, 2016
  • Articles

Nutraceuticals: Rich in potential

Nutraceuticals: Rich in potential

Published in eyeforpharma October 2016 by Marc Yates

A shift to preventative health will see nutraceuticals emerge as a growth area across mature and emerging markets.
The strong growth and globalization of the nutraceuticals sector may be down to the ingenuity of brand managers as much as food scientists, but it also reveals a lot about current trends in healthcare and the cultural, economic or demographic factors underlining them, across both mature and emerging markets. What is interesting about the nutraceuticals boom is that no-one has really agreed yet what these products are exactly, or at least where they sit in standardized legal and regulatory terms either at country level or worldwide.

read more »

Client Testimonial "You took time to understand our business..."

"You took time to understand our business, our customers and always came up with high level deliverables at each step of the project."
Market Research Manager 
 

read more »

  • Posted by Laurent Chanroux
  • November 7, 2016
  • Events

Therapy Watch to present “real-world” patient data at Rheumatology ACR conference in Washington on November 11-16

Therapy Watch to present “real-world” patient data at Rheumatology ACR conference in Washington on November  11-16

We are delighted to have been chosen to present two posters at this year’s ACR conference in Washington on November  11-16. The posters, which are entitled, ‘A Real World View of Rheumatoid Arthritis Patients Treated with Advanced Therapies’ and ‘Patient Adherence with Biologic Therapy in RA’ are authored by Research Director Laurent Chanroux.

read more »

Qualitative research with payers in low and middle income countries

Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in low and middle income countries where patients self-pay for healthcare.
They also wanted to obtain a deep understanding of the groups of patients for whom self-pay is an issue and the sources of public funding that could potentially be leveraged. Our findings would complement market access considerations and point the way forward to a self-pay strategy that would maximise the potential for our client’s product.

read more »

  • Posted by Sue Marett
  • November 3, 2016
  • Webinars

Immuno-oncology's evolution: Implications for pharma market researchers

Immuno-oncology's evolution: Implications for pharma market researchers

In association with PMGroup

Immuno-oncology therapies that harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. Until recently only a few products had reached the market for a limited number of indications.
However, over the past 12 months several new products have been approved for a wider range of tumour types and with numerous other products in the pipeline, competition looks set to hot up.

read more »